EVILEAD-FI: Evidence-based Leadership in Nurse Leaders-FI

Sponsor
University of Turku (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05244512
Collaborator
Central South University (Other), Sichuan University (Other), University of Ottawa (Other), Swinburne University of Technology (Other)
140
1
2
17
8.2

Study Details

Study Description

Brief Summary

This study protocol describes a randomised feasibility trial that will evaluate the feasibility and preliminary effectiveness of the training course to improve evidence-based leadership competencies among nurse leaders working in hospitals in Finland.

Condition or Disease Intervention/Treatment Phase
  • Other: Evidence-based leadership training
  • Other: Conventional training
N/A

Detailed Description

This study will include a 6-months training intervention for nurse leaders working in hospital settings in Finland. About 140 nurse leaders fulfilling the eligibility criteria will be randomly allocated (1:1) to participate in the online training course about evidence-based leadership or conventional leadership training course (reading material only).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A single-blind, individually randomised, two-arm parallel-group controlled feasibility trial design will be used.A single-blind, individually randomised, two-arm parallel-group controlled feasibility trial design will be used.
Masking:
Double (Participant, Care Provider)
Masking Description:
Tutors and researchers involved in the screening and baseline assessment will not be blind to the interventions provided during the trial. Participants, care providers and statistician will be kept blind to the study conditions.
Primary Purpose:
Health Services Research
Official Title:
Online Training to Improve Evidence-based Leadership Competencies Among Nurse Leaders in Finland: Study Protocol for a Randomised Feasibility Trial (EVILED-FI)
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Evidence-based leadership training

The training course will take 6 months. It is divided into seven online modules. Participants join the course based on pre-structured schedule. The progress of the training course will follow specific steps to improve participants' evidence-based leadership competencies. First, each participant identifies one leadership problem on daily practice. Second, organisational data will be collected and analysed to increase the understanding of the key problem. Third, scientific literature will be searched, identified and critically appraised to find solutions. Fourth, the views of stakeholders (patients, clinicians, family members, etc.) are considered together with ethical implications. And last, all sources of information are critically appraised, new solution will be designed and implemented into the practice, and evaluated in real world context. Each module includes specific learning material. Trained tutors are responsible for mentoring each module.

Other: Evidence-based leadership training
7-modules online training over six months mentored by tutors. Independent familiarisation of reading material, peer-group discussions, self-reflection, assignments, tutor's feedback.

Active Comparator: Conventional training

The participants will join a training course with the same structure, topics, and timing as the experimental group. However, training in this group is based on independent learning methods. The participants have access to the separate learning platform, which includes reading material to be read independently. No group discussions with peers, self-reflection, assignments, or support from tutors will be offered.

Other: Conventional training
7-modules online training over six months. Independent reading only.

Outcome Measures

Primary Outcome Measures

  1. Acceptability of the intervention [6 months]

    The degree of execution (success and failure of execution) of the intervention protocol by calculating the number of logins for each module and all participants

  2. Adherence in the course [6 months]

    Adherence in the course by calculating the number of returned course tasks out of all possible tasks

  3. Adherence in the course tasks [6 months]

    Adherence in the course by calculating the number of returned course tasks by each participant

  4. Drop-out rate [6 months]

    The drop-out rate calculated by the number of participants who left the study early (no follow-up data)

Secondary Outcome Measures

  1. Acceptability in recruitment [Baseline]

    The number of nurse leaders who accepted (or refused) the invitation to participate in the research study

  2. Feasibility of the eligibility criteria [Baseline]

    The number of nurse leaders who fulfilled eligibility criteria

  3. Feasibility of the outcome instruments for measuring the potential effectiveness of the online course [Baseline and 6 months]

    The number of missing variables of each returned instrument

  4. Leadership skills (Multifactor Leadership Questionnaire [MLQ]) [Baseline and 6 months]

    Multifactor Leadership Questionnaire (MLQ)

  5. Evidence-based practice, knowledge, and attitudes (Evidence Based Practice Questionnaire [EBPQ]) [Baseline and 6 months]

    Evidence-Based Practice Questionnaire (EBPQ)

  6. Self-efficacy (General Self-Efficacy Scale [GSE]) [Baseline and 6 months]

    General Self-Efficacy Scale (GSE)

  7. Self-esteem (Rosenberg Self-Esteem Scale [RSE]) [Baseline and 6 months]

    Rosenberg Self-Esteem Scale (RSE)

  8. Intention to leave (questionnaire) [Baseline and 6 months]

    Three-item questionnaire

  9. Course feedback [6 months]

    Eight-item questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Official managerial role in the study organisation (hospital, clinic, ward level), which give them an authority to act as a nurse leader and monitor, develop and evaluate the care

  • Being in full time or part time position

  • All sex

  • Aged up to 65 years

  • Working in the study sites at the time of the recruitment

  • Ability to read and write Finnish language

  • Willingness to join the study based on their own free will

  • Informed consent obtained

Exclusion Criteria:
  • Non-nursing professionals in leadership position (e.g. physician, psychologist, pharmacist, dietician/nutritionist, dentist, physiotherapist, radiation therapist, paramedic, occupational therapist, social worker, or disability worker)

  • Speaking only other languages than Finnish (e.g. Swedish or English)

  • Out of duty during the recruitment period for family leave, long term sick leave, study leave or any other reason

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Turku Turku Finland 20014

Sponsors and Collaborators

  • University of Turku
  • Central South University
  • Sichuan University
  • University of Ottawa
  • Swinburne University of Technology

Investigators

  • Principal Investigator: Maritta A Välimäki, University of Turku

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Maritta Välimäki, Professor, University of Turku
ClinicalTrials.gov Identifier:
NCT05244512
Other Study ID Numbers:
  • UTUEvidence
First Posted:
Feb 17, 2022
Last Update Posted:
May 26, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Maritta Välimäki, Professor, University of Turku

Study Results

No Results Posted as of May 26, 2022